EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Relationship Between (Endo)cannabinoids, the Microbiome and Melanoma

Farideh A Javid iD, Marin Golčić, Anja Harej Hrkać, Andrej Belančić iD

Pharmacology Research & Perspectives · 2026-08 · 14 (4)

DOI: 10.1002/prp2.70304 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmacology Research & Perspectives, online erschienen am 31.07.2026. Verfasst von Farideh A Javid und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Huddersfield, UK. Hauptthemen laut MEDLINE: Melanoma, Cannabinoids, Skin Neoplasms, Microbiota. Die Arbeit nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite advances in targeted and immunotherapy for melanoma, resistance to treatment and severe adverse effects pose significant challenges. This necessitates the development of new treatment strategies, and cannabinoids, because of the extensive preclinical evidence for their cytotoxic action on carcinoma cells in a variety of cancers, can offer a novel therapeutic option when used appropriately. Indeed, the potential therapeutic benefits of cannabinoids were formally recognized in the world and much more recently in the United Kingdom when cannabis‐based medicinal products were moved from Schedule 1 of the Misuse of Drugs Regulations 2001 to Schedule 2 in 2018. This move further encouraged scientists to look at more applications of cannabinoids in different disorders. Although the potential psychoactivity of cannabis as a Schedule 1 drug hinders research, more research could focus on non‐psychoactive components such as cannabidiol (CBD) and cannabigerol (CBG). This review summarizes some past and current research on the relationship between the cannabinoid system and the microbiome in patients with metastatic melanoma who undergo immunotherapy. The review also provides a comprehensive background on the function of the cannabinoid system in normal and diseased skin, as well as future directions in using cannabinoids as an adjunct to chemotherapeutics in the treatment of the disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaCannabinoidsSkin NeoplasmsMicrobiotaHumansAnimalsImmunotherapyCannabidiolSkin Microbiome

Stichwörter der Autor:innen

cannabinoidsgut microbiomemelanomaskin cancer

Substanzen

CannabinoidsCannabidiolcannabigerol

Autor:innen und Institutionen

  • Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Huddersfield, UK.
  • Clinic for Tumors, Clinical Hospital Centre Rijeka, Rijeka, Croatia.
  • Department of Basic and Clinical Pharmacology With Toxicology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.

ORCID-Profile: Farideh A Javid, Andrej Belančić

Zitieren

APA

Javid, F. A., Golčić, M., Hrkać, A. H., & Belančić, A. (2026). The Relationship Between (Endo)cannabinoids, the Microbiome and Melanoma. Pharmacology Research & Perspectives, 14(4). https://doi.org/10.1002/prp2.70304

Vancouver

Javid FA, Golčić M, Hrkać AH, Belančić A. The Relationship Between (Endo)cannabinoids, the Microbiome and Melanoma. Pharmacology Research & Perspectives. 2026;14(4). doi:10.1002/prp2.70304

BibTeX
@article{Javid2026,
  author = {Javid, Farideh A and Golčić, Marin and Hrkać, Anja Harej and Belančić, Andrej},
  title = {The Relationship Between (Endo)cannabinoids, the Microbiome and Melanoma},
  journal = {Pharmacology Research & Perspectives},
  year = {2026},
  volume = {14},
  number = {4},
  doi = {10.1002/prp2.70304}
}
Kostenlos starten →